| Metric | სს სილკ მედიკალ | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾7.9m₾4.7m | ₾2.36bn₾2.11bn |
| Revenue growth | 67.6% | 11.8% |
| Profitability | ||
| EBITDA | ₾853k₾947k | — |
| EBITDA margin | 10.8%20.1% | — |
| Net profit | ₾853k₾947k | ₾1.24bn₾1.12bn |
| Net margin | 10.8%20.1% | 52.8%53.0% |
| Balance sheet | ||
| Total assets | ₾3.8m₾2.9m | ₾37.66bn₾31.77bn |
| Total equity | ₾1.9m₾1.1m | ₾5.45bn₾4.75bn |
| ROE | 44.3%88.4% | 22.8%23.6% |